Transglutaminase 2 in the balance of cell death and survival.
about
Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivationTransglutaminase 2 contributes to apoptosis induction in Jurkat T cells by modulating Ca2+ homeostasis via cross-linking RAP1GDS1Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathProtein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional proteinCellular functions of tissue transglutaminasePhysiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2Role of transglutaminase 2 in celiac disease pathogenesisEffects of the regulatory ligands calcium and GTP on the thermal stability of tissue transglutaminase.Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.Novel method for extracting exosomes of hepatocellular carcinoma cells.Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.Bcr is a substrate for Transglutaminase 2 cross-linking activity.Fungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase.Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of BaxCharacterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological statesActivation of the mTOR signaling pathway in breast cancer MCF‑7 cells by a peptide derived from Porphyra yezoensis.Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic interventionRole of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.Two isoforms of tissue transglutaminase mediate opposing cellular fates.Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation.Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression.Fission yeast Cyk3p is a transglutaminase-like protein that participates in cytokinesis and cell morphogenesis.Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cellsCatalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica ObliteransTransglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a reviewDoxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell deathMethylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1.Senescence and programmed cell death in plants: polyamine action mediated by transglutaminase.Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.Effects of transglutaminase 2 inhibition on ventilator-induced lung injury.Potential of transglutaminase 2 as a therapeutic target.Problems associated with fluid biomarkers for Parkinson's disease.Evidences for a role of protein cross-links in transglutaminase-related disease.
P2860
Q21560855-D8BD4941-C20B-47F0-8B19-1B8602661438Q24314349-2EFD7AA1-E66B-4C61-8D0C-6BD93E618DE1Q28069852-3A79AD02-F51F-43D6-A955-A2A37E5A2C40Q28247511-42EEC7CF-E364-4EB4-BCF0-881A442D7549Q28260600-3B0D16EF-9BEE-4B8C-A996-F2E1C1C093E6Q28261578-F9AF4FCB-6D4F-41E4-AD35-DAE88F4BFBAAQ28262529-41E40C8B-E723-4747-A0D6-E0355D2D2221Q30404253-9760C090-BD1E-40B1-8C43-73FE98667D83Q33380424-8095BC2A-6863-41A6-88DD-C57CCED04ED2Q33476870-EEFC3238-45BD-4BFB-8E93-A2954CEF178FQ33660874-70D393CB-C2D3-4838-B792-A4FB20FCAA90Q33718359-862EE169-43E5-4B7E-9329-3F2ABE5DF90CQ33809160-452389DF-3637-4F80-8233-EAF21DBADB26Q33817561-1966516F-05E9-4764-BD25-F051614C5629Q33881464-5709D6B4-B021-4B13-99D2-32D6422FF5D2Q34161250-3EA6EF48-3778-42AD-8F8A-8D125D926B63Q34517980-0037C53D-B340-421A-89C1-C5E17848E475Q34626081-94AF61A9-9566-4348-BD55-3CE70C69299DQ34927039-353E07B8-F120-4C9A-B602-7541D900D723Q35147626-7C20C65A-FA24-43FF-8E7A-D1B156AC5D25Q35157424-A8FD5713-7DAA-49F3-9EE5-E5BB3A0DF481Q35697155-D20750FD-E740-4CFF-B531-B507DB91DC5DQ36003028-7C5F7579-8DEF-4F1F-9967-C422A8300CAFQ36066623-CC259342-50F9-4B5E-89F6-378ADBC77F10Q36485122-F62009B3-AF48-416E-9835-2D98E92325A2Q36536417-05E4BC1E-3B13-411D-A35F-C7806509371BQ36539483-03BC9742-03AE-43F5-9574-0D9202AB1F30Q37124999-0F7EE7A6-7556-4170-98AC-A2699EDA1078Q37286621-7B8F233A-F025-485C-B1BE-493676ECF930Q37406648-28BD2D05-5910-488F-8897-015E856E7350Q37418238-CE70C008-8307-4587-BF0E-6D709153081FQ37461477-7A700159-3C54-4B81-8553-AECFD8455827Q37541015-E86D7FE2-D77F-433D-B4FF-BEFFD7559946Q37700254-3F747180-1AC1-4FC5-9FC6-C5689BBD5408Q37700761-1FAB4E7D-E718-4B2D-A2AE-8C36A71C4F7FQ37707832-D12CDFB2-B4C0-4B37-B758-66A5F74CD2E4Q37710375-5F81C7C0-2707-4444-B28F-3B0B600F4A6BQ37776508-EF05EC27-D466-411B-BAB3-46239F4FC0FEQ37800100-870D2018-7DC8-4A7B-B61A-CD7898E185ACQ37907975-5F796BE0-FDCA-47DA-807A-0DB2D3685B2E
P2860
Transglutaminase 2 in the balance of cell death and survival.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Transglutaminase 2 in the balance of cell death and survival.
@ast
Transglutaminase 2 in the balance of cell death and survival.
@en
type
label
Transglutaminase 2 in the balance of cell death and survival.
@ast
Transglutaminase 2 in the balance of cell death and survival.
@en
prefLabel
Transglutaminase 2 in the balance of cell death and survival.
@ast
Transglutaminase 2 in the balance of cell death and survival.
@en
P2860
P1433
P1476
Transglutaminase 2 in the balance of cell death and survival.
@en
P2093
László Fésüs
Zsuzsa Szondy
P2860
P304
P356
10.1016/J.FEBSLET.2005.03.063
P407
P577
2005-04-07T00:00:00Z